Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for Genital HSV in HIV-Infected Persons with Low CD4 Count
NCT00079911Phase 4Terminated
- Sponsor
- GSK
- Start
- Mar 2004
- Primary completion
- Oct 2004
- Modality
- Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 4 trial of valaciclovir in genital herpes, sponsored by GSK. Started Mar 2004; status: terminated.
02
Drugs
valaciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00079911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079911.